Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ALKERMES    ALKS   

ALKERMES

 (ALKS)
4
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Biotechnology
Surperformance© rating of ALKERMES
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology
CountryTrading RatingInvestor Rating
GILEAD SCIENCES, INC.USA
AMGEN, INC.USA
BIOGEN IDEC INC.USA
CELGENE CORPORATIONUSA
CSL LIMITEDAUSTRALIA
REGENERON PHARMACEUTICALS INCUSA
VERTEX PHARMACEUTICALS INCORPORATEDUSA
LIFE TECHNOLOGIES CORP.USA
ACTELION LTDSwitzerland
ONYX PHARMACEUTICALS, INC.USA
PHARMACYCLICS, INC.USA
QIAGEN NVUSA
ALKERMESUSA
BEIJING SL PHARMACEUTICAL CO., LTD.CHINA
SEATTLE GENETICS, INC.USA
COVANCE INC.USA
LONZA GROUP AGSwitzerland
MEDIVATION INCUSA
JAZZ PHARMACEUTICALS PLCUSA
UNITED THERAPEUTICS CORPORATIONUSA
INCYTE CORPORATIONUSA
EUROFINS SCIENTIFICFrance
CELLTRION, INC.KOREA, REPUBLIC OF
PAREXEL INTERNATIONAL CORPORATIONUSA
TECHNE CORPORATIONUSA
Sector Biotechnology
Data source :
© 2013 Thomson Reuters		 Ratings :
© 2013 Surperformance
Advertisement
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.